Log in
Enquire now
‌

US Patent 10201624 Triazine based radiopharmaceuticals and radioimaging agents

Patent 10201624 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on February, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Molecular Insight Pharmaceuticals, Inc.
0
Current Assignee
‌
Molecular Insight Pharmaceuticals, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
102016240
Patent Inventor Names
John W. Babich0
Craig Zimmerman0
Genliang Lu0
John L. Joyal0
Date of Patent
February 12, 2019
0
Patent Application Number
152330960
Date Filed
August 10, 2016
0
Patent Citations Received
‌
US Patent 10898598 Triazine based radiopharmaceuticals and radioimaging agents
‌
US Patent 11712485 Triazine based radiopharmaceuticals and radioimaging agents
0
Patent Primary Examiner
‌
D. L. Jones
0
Patent abstract

Compounds according to Formula I and Formula II are potent inhibitors of PSMA.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10201624 Triazine based radiopharmaceuticals and radioimaging agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.